from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3406/-

LFCtreatmentdescriptionclass of inhibitor

-0.562

Amikacinug/mL Amikacintranslation

-0.148

Cap5-10ug/mL Capreomycintranslation

0.874

Rox10-50 ug/mL Roxithromycintranslation

0.053

SM2-5 ug/mL Streptomycintranslation

-0.306

Tet5-10 ug/mL Tetracyclinetranslation

-0.417

Rif0.2-5ug/mL Rifampicintranscription

-0.701

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.346

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.888

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.345

CPZ10-50 ug/mL Chlorpromazinerespiration

0.448

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.333

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.066

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.668

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.950

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.532

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.976

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.553

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.266

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.677

KCN5-20 ug/mL Potassium cyaniderespiration

-2.056

NaN30.2-2 mM Sodium aziderespiration

-0.881

Nigericin50 uM Nigericinrespiration

1.335

TRC10-150 ug/mL Triclosanrespiration

-0.185

TRZ10-25 ug/mL Thioridazinerespiration

1.493

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.356

menadione6-10 ug/mL Menadionerespiration

-0.284

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.538

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.466

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.145

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.068

NRP_1Non-replicating persistence stage 1dosRassociated

-0.212

Amp0.2mg/mL AmpicillincellWall

-0.451

Cephalexin20-100 ug/mL CephalexincellWall

0.105

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.286

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.381

EMB10-20 ug/mL EthambutolcellWall

-0.559

Eta12-40 ug/mL EthionamidecellWall

-1.013

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.271

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.472

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.662

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.024

BZA0.12 mg/mL BenzamidearomaticAmides

-0.346

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.864

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.393

H2O24 mM hydrogen peroxideDNAdamaging

-0.500

Levo10 ug/mL LevofloxacinDNAdamaging

-0.380

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.487

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.207

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.163

UVUV-irradiationDNAdamaging

0.645

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.562

Antimycin12.5-50 ug/mL Antimycin A?

-0.357

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.492

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.583

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.510

PA8240.2-2 ug/mL PA-824?

0.597

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.705

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.581

Verapamil50 uM Verapamil?

-0.652

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.235

methoxatin10-20 ug/mL Methoxatin?